StonvexLoading…
StonvexStonvexStonvexCore line items from LGIH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $319.74M | $1.71B | $1.23B | $834.90M |
Operating Income | $-582.00K | $79.78M | $61.26M | $39.78M |
Net Income | $2.16M | $72.55M | $55.23M | $31.53M |
EPS (Diluted) | $0.09 | $3.12 | $2.37 | $1.52 |
Total Assets | $4.01B | $3.93B | $4.04B | $4.01B |
Total Liabilities | $1.91B | $1.83B | $1.96B | $1.95B |
Cash & Equivalents | $60.86M | $61.25M | $61.98M | $59.56M |
Free Cash Flow OCF − CapEx | $-56.24M | $-140.90M | $-227.67M | $-214.41M |
Shares Outstanding | 23.23M | 23.13M | 23.08M | 23.06M |